Details for New Drug Application (NDA): 076642
✉ Email this page to a colleague
The generic ingredient in REPREXAIN is hydrocodone bitartrate; ibuprofen. There are twenty-three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.
Summary for 076642
Tradename: | REPREXAIN |
Applicant: | Amneal Pharms Ny |
Ingredient: | hydrocodone bitartrate; ibuprofen |
Patents: | 0 |
Pharmacology for NDA: 076642
Mechanism of Action | Cyclooxygenase Inhibitors Opioid Agonists |
Suppliers and Packaging for NDA: 076642
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
HYDROCODONE BITARTRATE AND IBUPROFEN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 076642 | ANDA | Amneal Pharmaceuticals of New York LLC | 53746-116 | 53746-116-01 | 100 TABLET in 1 BOTTLE (53746-116-01) |
HYDROCODONE BITARTRATE AND IBUPROFEN | hydrocodone bitartrate; ibuprofen | TABLET;ORAL | 076642 | ANDA | Amneal Pharmaceuticals of New York LLC | 53746-117 | 53746-117-01 | 100 TABLET in 1 BOTTLE (53746-117-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG;200MG | ||||
Approval Date: | Oct 12, 2004 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG;200MG | ||||
Approval Date: | Mar 18, 2004 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2.5MG;200MG | ||||
Approval Date: | Oct 19, 2007 | TE: | RLD: | No |
Complete Access Available with Subscription